Given the fact that HCC38, MDA-MB-231, and HCC1806 are classified in distinct subtypes of TN breast cancer cells [47], the results of inhibition of migration by attenuating CD44 exon v10 function may lead to a promising approach for inhibiting tumor progression and metastasis of any TN breast cancer cell types. This evidence concerns the gene CD44 and breast cancer.